NCT03238599View on ClinicalTrials.gov

Pedometer Activity Monitoring After ASCT

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

November 2, 2017

Primary Completion Date

February 15, 2022

Study Completion Date

March 1, 2022

Conditions
LymphomaMyelomaHigh-dose ChemotherapyAutologous Stem Cell Transplantation
Interventions
BEHAVIORAL

Pedometer-based activity monitoring after ASCT

Measurement of physical daily activity using a digital step counter (Pedometer-based activity monitoring) and assessment of patient well-being using a web-based patient reported tool.

Trial Locations (1)

3010

Departement of Medical Oncology, University Hospital Berne, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT03238599 - Pedometer Activity Monitoring After ASCT | Biotech Hunter | Biotech Hunter